Stock Scorecard



Stock Summary for Citius Pharmaceuticals Inc (CTXR) - $0.90 as of 3/28/2024 9:24:28 PM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CTXR

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CTXR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CTXR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for CTXR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for CTXR

Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ ( Denileukin Diftitox ) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma 3/18/2024 12:30:00 PM
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program 3/7/2024 1:30:00 PM
Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration 2/26/2024 12:30:00 PM
Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences 2/23/2024 1:30:00 PM
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update 2/14/2024 9:30:00 PM
Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors 1/23/2024 1:30:00 PM
Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters 1/2/2024 1:31:00 PM
Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters 1/2/2024 1:31:00 PM
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update 1/2/2024 1:30:00 PM
InnovationRx: Ransomware Attacks On U.S. Health Systems Have Cost The Economy Nearly $80 Billion 10/26/2023 12:42:00 AM

Financial Details for CTXR

Company Overview

Ticker CTXR
Company Name Citius Pharmaceuticals Inc
Country USA
Description Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Sector Name MANUFACTURING
Industry Name MOTOR VEHICLE PARTS & ACCESSORIES
Most Recent Quarter 12/31/2023
Next Earnings Date 5/10/2024

Stock Price History

Last Day Price 0.90
Last Day Price Updated 3/28/2024 9:24:28 PM EST
Last Day Volume 1,272,216
Average Daily Volume 625,425
52-Week High 1.71
52-Week Low 0.60
Last Price to 52 Week Low 50.00%

Valuation Measures

Trailing PE N/A
Industry PE 49.09
Sector PE 34.29
5-Year Average PE -6.17
Free Cash Flow Ratio 6.92
Industry Free Cash Flow Ratio 28.85
Sector Free Cash Flow Ratio 45.78
Current Ratio Most Recent Quarter 5.06
Total Cash Per Share 0.13
Book Value Per Share Most Recent Quarter 0.53
Price to Book Ratio 1.51
Industry Price to Book Ratio 2.36
Sector Price to Book Ratio 5.09
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 0.94
Sector Price to Sales Ratio Twelve Trailing Months 2.24

Share Statistics

Total Shares Outstanding 159,095,000
Market Capitalization 143,185,500
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 3.26%
Reported EPS 12 Trailing Months -0.26
Reported EPS Past Year -0.06
Reported EPS Prior Year -0.23
Net Income Twelve Trailing Months -38,180,452
Net Income Past Year -32,542,912
Net Income Prior Year -33,640,646
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth -57.84%

Balance Sheet

Total Cash Most Recent Quarter 20,345,618
Total Cash Past Year 26,480,928
Total Cash Prior Year 41,711,690
Net Cash Position Most Recent Quarter 20,172,648
Net Cash Position Past Year 26,143,375
Long Term Debt Past Year 337,553
Long Term Debt Prior Year 337,553
Total Debt Most Recent Quarter 172,970
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 90,831,108
Total Stockholder Equity Prior Year 102,825,865
Total Stockholder Equity Most Recent Quarter 84,734,254

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.02
MACD Signal 0.01
20-Day Bollinger Lower Band 0.64
20-Day Bollinger Middle Band 0.76
20-Day Bollinger Upper Band 0.88
Beta 1.44
RSI 58.86
50-Day SMA 0.93
200-Day SMA 1.31

System

Modified 3/27/2024 10:17:48 PM EST